Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004–2015
Lu Zhang, Mei‐Chin Hsieh, Valentina I. Petkov, Qingzhao Yu, Yu‐Wen Chiu, Xiao‐Cheng Wu
Topics & Concepts
MedicineInternal medicineBreast cancerHazard ratioOncologyOdds ratioProportional hazards modelCancerGynecologyHormone receptorSurvival analysisConfidence intervalBreast Cancer Treatment StudiesBRCA gene mutations in cancerMale Breast Health Studies